Publications by authors named "David G Workman"

Claim this Profile
Q
Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents-A Novel Polymer Formulation for Anticancer Therapy.
Yvonne Lerchbammer-Kreith, Michaela Hejl, Nadine S Sommerfeld, Xian Weng-Jiang, Uchechukwu Odunze, David G Workman

Pharmaceuticals (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity.
David G Workman, Michael Hunter, Shuning Wang, Jérémy Brandel, Véronique Hubscher

Bioorg Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors.
Margarida Isabel Simão Carlos, Kai Zheng, Natalie Garrett, Natrah Arifin, David G Workman

Int J Pharm· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents.
David G Workman, Michael Hunter, Lynn G Dover, David Tétard

J Inorg Biochem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators.
David G Workman, Andrew Tsatsanis, Frank W Lewis, John P Boyle, Maryam Mousadoust

Metallomics· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis